The goals are to explain, at the biochemical and cellular levels, the high immunogenicity of the Listeria monocytogenes (LM) pore-forming toxin listeriolysin O (LLO). LLO provides dominant antigens for both CD4+ and CD8+ T cell responses on multiple MHC haplotypes. The LLO molecule has two notable dual functions, first, it is a strongly stimulatory protein (i.e., it has an "adjuvant" effect), inducing cytokine production and cell activation on the antigen presenting cells (APC). Second, LLO is an exceptional donor of antigens to the major histocompatibility class II molecules (MHC-II), eliciting strong T cell responses when given as a purified protein. Our hypothesis is that the strong avidity for cholesterol-rich membranes makes LLO a highly efficient immunogen. We want to take advantage of this feature to develop new knowledge on antigen processing and presentation biochemistry and to determine the relationship of LLO toxicity with its immunogenicity. We have chosen to focus on examining LLO as a purified protein, separate from the LM that normally expresses it. The benefits of this strategy are twofold: first, we can examine the immunogenicity of LLO in the absence of any other bacterial product that could change the biology of the APC, and, or induce an inflammatory effect;and second, we can take advantage of the known biochemistry of LLO. Examining the immunogenicity of LLO is important in order to: i) understand the natural infection and how LM antigens are presented;ii) explain LLO as an immunogen and a carrier molecule for ectopic antigens;and iii) provide us with unique clues on the basic mechanisms of antigen presentation.
In Aim 1, we describe the generation of an extensive series of LLO mutants that will be used to examine their immunogenicity both in vitro and in vivo. Mutagenesis of key amino acid residues on LLO will be informative in that it will allow us to probe the biochemical and biological features that makes LLO such a strong immunogen;such as binding to membranes, trafficking pathways, possible association with other molecules involved in presentation, capacity to activate the APC, etc. Of course, the information will be of interest to those using LLO as a vaccine vehicle and to those who study cholesterol dependent cytolysins. The various LLOs will be tested in the context of basic presentation assays and used in all subsequent aims.
In Aim 2, we describe approaches for determining the localization and catabolism of LLO inside APC. The subcellular localization of LLO will be followed by different approaches including developing fluorescently-tagged LLOs. We also plan to examine the relationship between the induction of cell death and autophagic processes by LLO and its immunogenicity.
In Aim 3, we examine the adjuvanticity of LLO in three contexts: i) activation of APC, ii) priming of naive T cells, and iii) generation of protective immunity to LM.

Public Health Relevance

We investigate immunity to the protein listeriolysin O, the major component that causes Listeria monocytogenes to be pathogenic. This protein is unique in its binding to cell surfaces and engenders an extremely powerful response. Studying the biochemical and cellular basis of such a protein will give us insights on how antigens are presented during microbial infection.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI062832-08
Application #
8277379
Study Section
Immunity and Host Defense Study Section (IHD)
Program Officer
Mills, Melody
Project Start
2004-12-01
Project End
2015-05-31
Budget Start
2012-06-01
Budget End
2013-05-31
Support Year
8
Fiscal Year
2012
Total Cost
$376,200
Indirect Cost
$128,700
Name
Washington University
Department
Pathology
Type
Schools of Medicine
DUNS #
068552207
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Lee, Sang Hun; Carrero, Javier A; Uppaluri, Ravindra et al. (2013) Identifying the initiating events of anti-Listeria responses using mice with conditional loss of IFN-ýý receptor subunit 1 (IFNGR1). J Immunol 191:4223-34
Carrero, Javier A; Unanue, Emil R (2012) Mechanisms and immunological effects of apoptosis caused by Listeria monocytogenes. Adv Immunol 113:157-74
Carrero, Javier A; Vivanco-Cid, Hector; Unanue, Emil R (2012) Listeriolysin o is strongly immunogenic independently of its cytotoxic activity. PLoS One 7:e32310
Unanue, Emil R; Carrero, Javier A (2012) Studies with Listeria monocytogenes lead the way. Adv Immunol 113:1-5
Aoshi, Taiki; Carrero, Javier A; Konjufca, Vjollca et al. (2009) The cellular niche of Listeria monocytogenes infection changes rapidly in the spleen. Eur J Immunol 39:417-25
Carrero, Javier A; Calderon, Boris; Vivanco-Cid, Hector et al. (2009) Recombinant Listeria monocytogenes expressing a cell wall-associated listeriolysin O is weakly virulent but immunogenic. Infect Immun 77:4371-82
Cadwell, Ken; Liu, John Y; Brown, Sarah L et al. (2008) A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells. Nature 456:259-63
Carrero, Javier A; Vivanco-Cid, Hector; Unanue, Emil R (2008) Granzymes drive a rapid listeriolysin O-induced T cell apoptosis. J Immunol 181:1365-74
Carrero, Javier A; Calderon, Boris; Unanue, Emil R (2006) Lymphocytes are detrimental during the early innate immune response against Listeria monocytogenes. J Exp Med 203:933-40
Carrero, Javier A; Unanue, Emil R (2006) Lymphocyte apoptosis as an immune subversion strategy of microbial pathogens. Trends Immunol 27:497-503